181 related articles for article (PubMed ID: 10737888)
1. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates.
Peter SJ; Lu L; Kim DJ; Stamatas GN; Miller MJ; Yaszemski MJ; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):452-62. PubMed ID: 10737888
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Lu L; Yaszemski MJ; Mikos AG
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
Lu L; Stamatas GN; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
[TBL] [Abstract][Full Text] [Related]
4. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2003 Sep; 91(3):299-313. PubMed ID: 12932709
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment.
Holland TA; Tessmar JK; Tabata Y; Mikos AG
J Control Release; 2004 Jan; 94(1):101-14. PubMed ID: 14684275
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer.
Heckman JD; Ehler W; Brooks BP; Aufdemorte TB; Lohmann CH; Morgan T; Boyan BD
J Bone Joint Surg Am; 1999 Dec; 81(12):1717-29. PubMed ID: 10608383
[TBL] [Abstract][Full Text] [Related]
8. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Yeh MK
J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421
[TBL] [Abstract][Full Text] [Related]
9. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. II: Osteoblastic differentiation.
Lieb E; Vogel T; Milz S; Dauner M; Schulz MB
Tissue Eng; 2004; 10(9-10):1414-25. PubMed ID: 15588401
[TBL] [Abstract][Full Text] [Related]
10. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
Hedberg EL; Shih CK; Lemoine JJ; Timmer MD; Liebschner MA; Jansen JA; Mikos AG
Biomaterials; 2005 Jun; 26(16):3215-25. PubMed ID: 15603816
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites.
Hedberg EL; Tang A; Crowther RS; Carney DH; Mikos AG
J Control Release; 2002 Dec; 84(3):137-50. PubMed ID: 12468217
[TBL] [Abstract][Full Text] [Related]
12. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 3. Proliferation and differentiation of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate).
Payne RG; McGonigle JS; Yaszemski MJ; Yasko AW; Mikos AG
Biomaterials; 2002 Nov; 23(22):4381-7. PubMed ID: 12219828
[TBL] [Abstract][Full Text] [Related]
13. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering.
Park H; Temenoff JS; Tabata Y; Caplan AI; Mikos AG
Biomaterials; 2007 Jul; 28(21):3217-27. PubMed ID: 17445882
[TBL] [Abstract][Full Text] [Related]
14. Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro.
Wake MC; Gerecht PD; Lu L; Mikos AG
Biomaterials; 1998 Jul; 19(14):1255-68. PubMed ID: 9720889
[TBL] [Abstract][Full Text] [Related]
15. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2005 Jan; 101(1-3):111-25. PubMed ID: 15588898
[TBL] [Abstract][Full Text] [Related]
16. Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite.
Peter SJ; Lu L; Kim DJ; Mikos AG
Biomaterials; 2000 Jun; 21(12):1207-13. PubMed ID: 10811302
[TBL] [Abstract][Full Text] [Related]
17. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
[TBL] [Abstract][Full Text] [Related]
18. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 2. Viability of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate).
Payne RG; McGonigle JS; Yaszemski MJ; Yasko AW; Mikos AG
Biomaterials; 2002 Nov; 23(22):4373-80. PubMed ID: 12219827
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers.
Ishaug-Riley SL; Crane-Kruger GM; Yaszemski MJ; Mikos AG
Biomaterials; 1998 Aug; 19(15):1405-12. PubMed ID: 9758040
[TBL] [Abstract][Full Text] [Related]
20. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers.
Yeh MK; Davis SS; Coombes AG
Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
